• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SOLYX SIS SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, FEMA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SOLYX SIS SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, FEMA Back to Search Results
Model Number M0068507000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Incontinence (1928); Unspecified Infection (1930); Pain (1994); Urinary Retention (2119); Injury (2348); Dysuria (2684); Insufficient Information (4580)
Event Date 04/12/2018
Event Type  Injury  
Manufacturer Narrative
Date of event was approximated to (b)(6) 2018, implant date, as no event date was reported.(b)(4).The complaint device is not expected to be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that a solyx sis system device was implanted into the patient during a procedure performed on (b)(6) 2018.According to the patient's attorney, after the implantation, the patient has experienced pain, dysuria, dyspareunia, urinary retention, incontinence, infections, erosion and urethral damage.Boston scientific has been unable to obtain additional information regarding the event to date.
 
Event Description
It was reported to boston scientific corporation that a solyx sis system device was implanted into the patient during a procedure performed on (b)(6) 2018.After the implantation, the patient has experienced pain, dysuria, dyspareunia, urinary retention, incontinence, infections, erosion and urethral damage.
 
Manufacturer Narrative
Additional information: section e block b3 date of event: date of event was approximated to (b)(6) 2018, implant date, as no event date was reported.Block e1: this event was reported by the patient's legal representation.The device was implanted at (b)(6).Block h6: patient codes e2006, e1309, e1906, e2330, e1301 and e2401 capture the reportable events of erosion, urinary retention, infections, pain and dyspareunia, dysuria, and urethral damage.Conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complaint device is not expected to be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLYX SIS SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, FEMA
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key10704966
MDR Text Key212131400
Report Number3005099803-2020-04548
Device Sequence Number1
Product Code PAH
UDI-Device Identifier08714729774044
UDI-Public08714729774044
Combination Product (y/n)N
PMA/PMN Number
K081275
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup
Report Date 04/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/30/2020
Device Model NumberM0068507000
Device Catalogue Number850-700
Device Lot Number0021320634
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/22/2020
Initial Date FDA Received10/20/2020
Supplement Dates Manufacturer Received03/24/2021
Supplement Dates FDA Received04/19/2021
Patient Sequence Number1
Patient Outcome(s) Other;
-
-